ATE528646T1 - Verfahren zur in-vitro-titration eines ncta und anwendung davon in einem verfahren zur bewertung und/oder überwachung eines herstellungsverfahrens für ein biologisches produkt - Google Patents

Verfahren zur in-vitro-titration eines ncta und anwendung davon in einem verfahren zur bewertung und/oder überwachung eines herstellungsverfahrens für ein biologisches produkt

Info

Publication number
ATE528646T1
ATE528646T1 AT04786344T AT04786344T ATE528646T1 AT E528646 T1 ATE528646 T1 AT E528646T1 AT 04786344 T AT04786344 T AT 04786344T AT 04786344 T AT04786344 T AT 04786344T AT E528646 T1 ATE528646 T1 AT E528646T1
Authority
AT
Austria
Prior art keywords
ncta
monitoring
application
evaluation
manufacturing process
Prior art date
Application number
AT04786344T
Other languages
English (en)
Inventor
Jean-Thierry Aubin
Benoit Flan
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Application granted granted Critical
Publication of ATE528646T1 publication Critical patent/ATE528646T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
AT04786344T 2003-08-25 2004-08-23 Verfahren zur in-vitro-titration eines ncta und anwendung davon in einem verfahren zur bewertung und/oder überwachung eines herstellungsverfahrens für ein biologisches produkt ATE528646T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0310126A FR2859222B1 (fr) 2003-08-25 2003-08-25 Methode d'evaluation et/ou de controle d'un procede d'obtention d'un produit biologique susceptible d'etre contamine par un agent transmissible non conventionnel (atnc)
PCT/FR2004/002179 WO2005022148A1 (fr) 2003-08-25 2004-08-23 Methode de titrage in vitro d’un atnc et son application a une methode d’evaluation et/ou de controle d’un procede d’obtention d’un produit biologique

Publications (1)

Publication Number Publication Date
ATE528646T1 true ATE528646T1 (de) 2011-10-15

Family

ID=34130588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04786344T ATE528646T1 (de) 2003-08-25 2004-08-23 Verfahren zur in-vitro-titration eines ncta und anwendung davon in einem verfahren zur bewertung und/oder überwachung eines herstellungsverfahrens für ein biologisches produkt

Country Status (12)

Country Link
EP (1) EP1658494B1 (de)
JP (1) JP2007503209A (de)
AT (1) ATE528646T1 (de)
AU (1) AU2004269188B2 (de)
BR (1) BRPI0413897A (de)
CA (1) CA2536688C (de)
DK (1) DK1658494T3 (de)
ES (1) ES2374816T3 (de)
FR (1) FR2859222B1 (de)
IL (1) IL173850A (de)
PL (1) PL1658494T3 (de)
WO (1) WO2005022148A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885369B1 (fr) * 2005-05-04 2010-11-12 Lab Francais Du Fractionnement Materiel infectieux synthetique et standardise de type prion et ses utilisations en tant qu'inoculum infectant.
FR2929290B1 (fr) * 2008-03-27 2010-05-07 Lfb Biotechnologies Methode de detection et/ou de titrage in vitro d'un agent transmissible non conventionnel
FR2935711A1 (fr) * 2008-09-05 2010-03-12 Lfb Biotechnologies Clone cellulaire stable exprimant un prion
FR2940446A1 (fr) 2008-12-22 2010-06-25 Lfb Biotechnologies Procede de detection d'une infection par prion
FR2998373B1 (fr) 2012-11-20 2015-01-09 Franklab Sas Procede de mesure de l'aptitude d'une formulation a inactiver un atnc.
FR3005576B1 (fr) 2013-05-15 2015-06-19 Lab Francais Du Fractionnement Procede d'inactivation d'une proteine prion
JP2021513913A (ja) * 2018-02-19 2021-06-03 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ 修正フィルタ膜及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605445B1 (en) * 1999-02-22 2003-08-12 Bayer Corporation Rapid method of determining clearance of prion protein

Also Published As

Publication number Publication date
IL173850A0 (en) 2006-07-05
JP2007503209A (ja) 2007-02-22
CA2536688A1 (fr) 2005-03-10
EP1658494B1 (de) 2011-10-12
ES2374816T3 (es) 2012-02-22
CA2536688C (fr) 2012-11-06
AU2004269188B2 (en) 2011-04-07
WO2005022148A1 (fr) 2005-03-10
FR2859222B1 (fr) 2006-01-27
BRPI0413897A (pt) 2006-10-24
FR2859222A1 (fr) 2005-03-04
AU2004269188A1 (en) 2005-03-10
EP1658494A1 (de) 2006-05-24
DK1658494T3 (da) 2012-01-09
IL173850A (en) 2012-02-29
PL1658494T3 (pl) 2012-05-31

Similar Documents

Publication Publication Date Title
DE602006019753D1 (de) Verfahren und gerät zur behandlung von aneurysmen der a. thoracica
DE60206739D1 (de) Giessform für ophthalmischen linsen enthaltend formgedächtnispolmer oder formgedächtnislegierung und verfahren zur herstellung ophthalmischer produkten
DE60324231D1 (de) Verfahren und Vorrichtung zur Behandlung eines Einsatzgases
DE602006006952D1 (de) Vorrichtung und Verfahren zur Personenidentifizierung
ATE541110T1 (de) Elektroakustisches verfahren und elektroakustische vorrichtung zur stimulierung von massentransferprozessen für eine verbesserte bohrlochförderung
DE602006009160D1 (de) Vorrichtung und Verfahren für Sprachverbesserung
EP1991274A4 (de) Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen
DE602008001180D1 (de) Vorrichtung und Verfahren zur Behandlung von Textilien
DE602004010705D1 (de) Vorrichtung und Verfahren zur Behandlung von Mist enthaltendem Abwasser
DE602005015569D1 (de) Verfahren und system zur pupillenerkennung für sicherheitsanwendungen
DE60304109D1 (de) Verfahren zur Herstellung von Ringelementen und Vorrichtung zu dessen Durchführung
ATE406605T1 (de) Verfahren zur überwachung und analyse eines papierherstellungsprozesses
DE50308109D1 (de) Klimaschrank sowie Vorrichtung und Verfahren zu seiner Überwachung
EP4106699C0 (de) Elastische verbundstruktur für ein absorbierendes hygieneprodukt sowie vorrichtung und verfahren zur herstellung dieser elastischen verbundstruktur
ATE475437T1 (de) Antimikrobielles medizintechnisches produkt, verfahren zu seiner herstellung und verwendung
ATE516290T1 (de) Verfahren zur herstellung von buprenorphin und derivaten von buprenorphin
WO2007035958A3 (en) Method, apparatus and software for identifying responders in a clinical environment
DE602006010267D1 (de) Verfahren und Apparat zur Herstellung von Harnstoff
DE502004011670D1 (de) Verfahren und Vorrichtung zur Herstellung von Polyurethan-Schaumstoffen
DE60303410D1 (de) Verfahren und Vorrichtung zur Herstellung von Tonern für Elektrofotografie
DE602007001004D1 (de) Vorrichtung für die Verneblung einer flüssigen Substanz zur Behandlung von Obst und Gemüse und deren Verwendung
EP4392368C0 (de) Doppeldrucksystem zur herstellung von salpetersäure und verfahren zum betrieb davon
IL173850A0 (en) Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method
DE50309719D1 (de) Verfahren zur Herstellung von faserverstärktem Halbzeug in Form von Metallbändern, Metallblechen oder dergleichen sowie Vorrichtung zur Durchführung des Verfahrens
DE60308066D1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1658494

Country of ref document: EP